Richard Ammer

Insider Reports History

Entity
Individual
Location
C/O Vallon Pharmaceuticals, Inc., 100 N. 18 Th Street, Suite 300, Philadelphia, PA
Signature
/s/ David Baker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Ammer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 7.5K Jun 9, 2022 Direct

Insider Reports Filed by Richard Ammer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRI Vallon Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
GRI Vallon Pharmaceuticals, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director